Premium Information is available for this item - Upgrade for $1 a day
6505-01-180-6913
Usp Diatrizoate Meglumine Injection
6505011806913 011806913 ANGIOVIST 282 NDC50419-0192-15 019215
INC: 23817 Diatrizoate Meglumine Injection
January 2023
5

Marketplace 6505-01-180-6913
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-180-6913 5+ Documents (More...)
RQST NE Updated Every Day 6505-01-180-6913 RQST Updated Every Day 6505-01-180-6913 RQST NE Related Documents
6505-01-180-6913 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-180-6913
Usp Diatrizoate Meglumine Injection 0172 us 6505-01-180-6913 https//www.nsnlookup.com https//www.nsnlookup.com
Meglumine Injection Usp Diatrizoate Meglumine Injection ,02-0172 6505-27-004-7253 6505-00-007-4538 6505-01-180-6913
Usp Diatrizoate Meglumine Injection www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-180-6913 https
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-153-3717 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-180-6913
Usp Diatrizoate Meglumine https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-180-6913 Usp Diatrizoate
https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505 https /www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-180-6913
Usp Diatrizoate Meglumine Injection 180-6913Usp Diatrizoate Meglumine Injection6505011806913 011806913
ANGIOVIST 282 NDC50419-0192-15 019215 Meglumine Injection,02-0172 us 6505-01-180-6913 https//www.nsnlookup.com
Restrictions 6505-01-180-6913
6505-01-180-6913 is a Usp Diatrizoate Meglumine Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-180-6913
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-180-6913
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-180-6913
- Part Number
- Manufacturer
- Status
- NDC50419-0192-15
- Manufacturer
- 59463 - Bayer Healthcare Pharmaceuticals Inc (Active)
- Primary Buy
- Primary Buy
- 019215
- 59463 - Bayer Healthcare Pharmaceuticals Inc (Active)
- Primary Buy
- Primary Buy
- ANGIOVIST 282
- 59463 - Bayer Healthcare Pharmaceuticals Inc (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-180-6913
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Active Medicament Medicinal Strength [AKJA]
- 60.000 Percentage, W/V Meglumine Diatrizoate Active Ingredient
- Pharmaceutical Vehicle Type [AKJQ]
- Any Acceptable
- Administration [CSGS]
- Intravenous Infusion
- Primary Container Type [CQCT]
- Vial
- Primary Container Content Quantity [CRLK]
- 150.000 Milliliters
- Total Primary Container Quantity [CSCW]
- 20
- Special Features [FEAT]
- Stopper Shall Be Compatible With Piercing Device Of The Stock Listed Intravenous Injection Sets; With Hangers
Management Data 6505-01-180-6913
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Jun 1984
- Veterans Administration (VA)
- VI
- Subscribe
- VI
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 150 Ml
- 00000000150ML
- K
Similar Supply Items to 6505-01-180-6913


















Freight Information 6505-01-180-6913
6505-01-180-6913 has freight characteristics.. 6505-01-180-6913 has a variance between NMFC and UFC when transported by rail and the description should be consulted.